Physicochemical characterization of allergens: quantity, identity, purity, aggregation and conformation.
Allergens and allergoids can be characterized by means of physicochemical methods, resulting in a description of the protein on different structural levels. Several techniques are available and their suitability depends on the composition of the particular sample. Current European legislation on allergen products demands characterization of final products in particular focusing on identity, degree of modification (for allergoids) and stability of the composition. Structural parameters of allergens may be used to investigate the stability of an allergen product. The challenge is to identify and optimize techniques that allow determination of protein structure in the context of a formulated pharmaceutical product. As the majority of the products currently marketed are formulated with aluminium hydroxide or aluminium phosphate as a depot, most of the methods and techniques used for protein characterization in solution are not applicable. An additional hurdle is that allergen products are based on natural extracts, comprising a mixture of proteins, both allergens and non-allergens, sometimes in the presence of other uncharacterized components from the raw material. This paper describes which methods are suitable for the different stages of allergen product manufacturing, and how these relate to the current regulatory requirements. Some of the techniques are demonstrated using a model allergen, cod parvalbumin, and a chemically modified form thereof. We conclude that a variety of methods is available for characterization of proteins in solution, and that a limited number of techniques appear to be suitable for modified allergens (allergoids). Adaptation of existing methods, e.g. mass spectroscopy and infrared spectroscopy may be helpful to obtain protein parameters of allergens in a formulated allergen product. By choosing a combination of techniques, including those additional to physicochemical approaches, relevant parameters of allergens in formulated allergen products can be assessed in order to achieve a well-characterized pharmaceutical product.
Koppelman
Stef J
SJ
HAL Allergy, Leiden.
Luykx
Dion M A M
DM
de Jongh
Harmen H J
HH
Veldhuizen
Willem Jan
WJ
D000485:Allergens / Q000032:analysis* / Q000737:chemistry; D000818:Animals; D001685:Biological Factors / Q000032:analysis / Q000737:chemistry / Q000592:standards; D055598:Chemical Phenomena; D005062:European Union; D029941:Fish Proteins / Q000032:analysis / Q000737:chemistry / Q000276:immunology; D048388:Gadiformes / Q000276:immunology; D033161:Government Regulation; D017408:Guidelines as Topic; D006801:Humans; D046912:Multiprotein Complexes / Q000737:chemistry; D010320:Parvalbumins / Q000032:analysis / Q000737:chemistry / Q000276:immunology; D011487:Protein Conformation; D055550:Protein Stability
D000485:Allergens; D001685:Biological Factors; D029941:Fish Proteins; D046912:Multiprotein Complexes; D010320:Parvalbumins